Question
How should the NAP score issue in peripheral blood be handled? Are there effective treatment methods? I request professional medical advice from doctors.
Answer
The content of stem/progenitor cells in peripheral blood accounts for about 0.01% to 0.1% of individual nucleated cells, which is equivalent to 1% to 10% of the bone marrow. After mobilization, the number of CD34+ cells and CFU in peripheral blood MNCs is significantly higher than that in bone marrow. However, diagnosis not only depends on auxiliary examinations but also requires consideration of whether the patient has symptoms such as splenomegaly, sternum pain, as well as manifestations such as anemia, bleeding, and infection. It is recommended that patients should communicate and consult with doctors in detail to obtain more comprehensive medical advice.